Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Frye

Showing results (101-110 of 518) with videos related to

Pageof 52
Sort By:
Bipolar Disorders|April 19, 2012
The clinical management of bipolar disorder complexity using a stratified modelGin S Malhi, Danielle M Bargh, Emma Cashman, et al.
The Journal of Clinical Psychiatry|November 24, 2004
Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sampleJoseph R Calabrese, Robert M A Hirschfeld, Mark A Frye, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 14, 2012
Short TE (7) Li-MRS confirms Bi-exponential lithium T2 relaxation in humans and clearly delineates two patient subtypesJohn D Port, Karen E Rampton, Yunhong Shu, et al.
Pharmacogenomics|September 6, 2021
Genetics and antiepileptic mood stabilizer treatment response in bipolar disorder: what do we know?Ada Man-Choi Ho, Richard M Weinshilboum, Mark A Frye, et al.
General Hospital Psychiatry|February 7, 2012
Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and managementAmit Chopra, Bhanu Prakash Kolla, Meghna P Mansukhani, et al.
Cell Reports|February 21, 2020
Inhibitory Interactions and Columnar Inputs to an Object Motion Detector in DrosophilaMehmet F Keleş, Ben J Hardcastle, Carola Städele, et al.
International Journal of Bipolar Disorders|September 3, 2015
Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatmentsMark A Frye, Jess Amchin, Michael Bauer, et al.
The Journal of Clinical Psychiatry|October 5, 2002
Subsyndromal depression is associated with functional impairment in patients with bipolar disorderLori L Altshuler, Michael J Gitlin, Jim Mintz, et al.
Biological Psychiatry|June 1, 2006
Low cerebrospinal fluid glutamate and glycine in refractory affective disorderMark A Frye, Guochuan E Tsai, Teresa Huggins, et al.
Journal of Affective Disorders|February 1, 2024
Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamineBalwinder Singh, Jennifer L Vande Voort, Vanessa K Pazdernik, et al.
Pageof 52

Showing results (101-110 of 518) with videos related to

Sort By:
Pageof 52
Bipolar Disorders|April 19, 2012
The clinical management of bipolar disorder complexity using a stratified modelGin S Malhi, Danielle M Bargh, Emma Cashman, et al.
The Journal of Clinical Psychiatry|November 24, 2004
Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sampleJoseph R Calabrese, Robert M A Hirschfeld, Mark A Frye, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 14, 2012
Short TE (7) Li-MRS confirms Bi-exponential lithium T2 relaxation in humans and clearly delineates two patient subtypesJohn D Port, Karen E Rampton, Yunhong Shu, et al.
Pharmacogenomics|September 6, 2021
Genetics and antiepileptic mood stabilizer treatment response in bipolar disorder: what do we know?Ada Man-Choi Ho, Richard M Weinshilboum, Mark A Frye, et al.
General Hospital Psychiatry|February 7, 2012
Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and managementAmit Chopra, Bhanu Prakash Kolla, Meghna P Mansukhani, et al.
Cell Reports|February 21, 2020
Inhibitory Interactions and Columnar Inputs to an Object Motion Detector in DrosophilaMehmet F Keleş, Ben J Hardcastle, Carola Städele, et al.
International Journal of Bipolar Disorders|September 3, 2015
Randomized, placebo-controlled, adjunctive study of armodafinil for bipolar I depression: implications of novel drug design and heterogeneity of concurrent bipolar maintenance treatmentsMark A Frye, Jess Amchin, Michael Bauer, et al.
The Journal of Clinical Psychiatry|October 5, 2002
Subsyndromal depression is associated with functional impairment in patients with bipolar disorderLori L Altshuler, Michael J Gitlin, Jim Mintz, et al.
Biological Psychiatry|June 1, 2006
Low cerebrospinal fluid glutamate and glycine in refractory affective disorderMark A Frye, Guochuan E Tsai, Teresa Huggins, et al.
Journal of Affective Disorders|February 1, 2024
Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamineBalwinder Singh, Jennifer L Vande Voort, Vanessa K Pazdernik, et al.
Pageof 52